NextCure, Inc. (NXTC)

NextCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.08	26.63	12.34	34.48	35.8
Short-Term Investments	95.22	133.28	207.25	250.68	300.51
Cash & Cash Equivalents	108.3	159.91	219.59	285.15	336.31
Cash Growth	-32.28%	-27.18%	-22.99%	-15.21%	147.96%
Other Current Assets	4.43	4.07	8.23	2.82	3.68
Total Current Assets	112.73	163.98	227.82	287.98	340
Property, Plant & Equipment	13.43	16.91	13.99	15.81	12.09
Other Long-Term Assets	1.88	3.27	0.58	2.86	4.08
Total Long-Term Assets	15.31	20.18	14.57	18.67	16.17
Total Assets	128.04	184.16	242.39	306.64	356.17
Accounts Payable	2.33	4.27	1.94	3.9	1.86
Deferred Revenue	0	0	0	0	22.38
Current Debt	0	0	0	1.67	1.67
Other Current Liabilities	4.55	4.86	4.67	4.76	-10.86
Total Current Liabilities	6.88	9.13	6.61	10.33	15.04
Long-Term Debt	5.95	6.61	0	1.81	3.33
Other Long-Term Liabilities	0.79	0.9	2.39	0.79	16.31
Total Long-Term Liabilities	6.73	7.5	2.39	2.6	19.64
Total Liabilities	13.62	16.63	9	12.92	34.68
Total Debt	5.95	6.61	0	3.47	5
Debt Growth	-9.93%	-	-	-30.54%	986.96%
Retained Earnings	-324.48	-261.76	-187.03	-117.64	-81.03
Comprehensive Income	-0.22	-1.49	-0.66	0.78	-0.04
Shareholders' Equity	114.42	167.53	233.39	293.72	321.48
Net Cash / Debt	102.35	153.31	219.59	281.68	331.31
Net Cash / Debt Growth	-33.24%	-30.19%	-22.04%	-14.98%	145.10%
Net Cash Per Share	3.68	5.53	7.95	10.23	21.11
Working Capital	105.84	154.86	221.21	277.65	324.95
Book Value Per Share	4.11	6.04	8.45	10.67	20.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).